Trial
NCT00881556
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Columbia University
Collaborators
—
Condition
Epidermolysis Bullosa
Intervention
Palifermin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-17